Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma

Neuro-Oncology

Volumn 14, Issue 9, 2012, Pages 1153-1162

  Ma, Xinlong ^a   Yoshimoto, Koji ^a   Guan, Yaulei ^a   Hata, Nobuhiro ^a   Mizoguchi, Masahiro ^a   Sagata, Noriaki ^a   Murata, Hideki ^a   Kuga, Daisuke ^a   Amano, Toshiyuki ^a   Nakamizo, Akira ^a   Sasaki, Tomio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Glioma; Mesenchymal; microRNA; miR 128a; miR 504

Indexed keywords

CELL MARKER; HERMES ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 105; MICRORNA 124A; MICRORNA 128A; MICRORNA 135B; MICRORNA 15B; MICRORNA 184; MICRORNA 196A; MICRORNA 196B; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 203; MICRORNA 21; MICRORNA 302A; MICRORNA 302B; MICRORNA 302C; MICRORNA 302D; MICRORNA 34A; MICRORNA 363; MICRORNA 367; MICRORNA 504; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN TYROSINE KINASE; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN;

ARTICLE; ASTROCYTOMA; CANCER PATIENT; CANCER STEM CELL; CONTROLLED STUDY; DIFFUSE ASTROCYTOMA; DISEASE SEVERITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MARKER GENE; MESENCHYME; NEUROSURGERY; OLIGODENDROGLIOMA; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADIPOKINES; ANTIGENS, CD44; BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; LECTINS; LOSS OF HETEROZYGOSITY; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 84867500546     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos145     Document Type: Article

References (33)

1. Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004;64(18):6503-6510.
2. Fuller GN, Hess KR, Rhee CH, et al. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathol. 2002;12(1):108-116.
3. Sulman EP, Aldape K. The use of global profiling in biomarker development for gliomas. Brain Pathol. 2011;21(1):88-95.
4. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009;136(4):586-591.
5. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-269.
6. Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and a poptosis. Eur J Cancer. 2011;47(8):1127-1137.
7. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005;353(17):1768-1771.
8. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-866.
9. Guan Y, Mizoguchi M, Yoshimoto K, et al. MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res. 2010;16(16):4289-4297.
10. Wuchty S, Arjona D, Li A, et al. Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One. 2011;6(2):e14681.
11. Bandyopadhyay S, Mitra R, Maulik U, Zhang MQ. Development of the human cancer microRNA network. Silence. 2010;1(1):6.
12. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3):157-173.
13. Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110.
14. Huse JT, Phillips HS, Brennan CW. Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia. 2011;59(8):1190-1199.
15. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
16. Natsume A, Kinjo S, Yuki K, et al. Glioma-initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol. 2011;28(1):1-12.
17. Yoshimoto K, Ma X, Guan Y, et al. Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR. Brain Tumor Pathol. 2011;28(4):291-296.
18. Tso CL, Shintaku P, Chen J, et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006;4(9):607-619.
19. Carro MS, Lim WK, Alvarez MJ, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature. 2010;463(7279):318-325.
20. Lawler S, Chiocca EA. Emerging functions of microRNAs in glioblastoma. J Neurooncol. 2009;92(3):297-306.
21. Malzkorn B, Wolter M, Liesenberg F, et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2010;20(3):539-550.
22. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009;13(1):39-53.
23. Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008;68(19):8164-8172.
24. Hermeking H. p53 enters the microRNA world. Cancer Cell. 2007;12(5):414-418.
25. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010;17(2):193-199.
26. Li Y, Guessous F, Zhang Y, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69(19):7569-7576.
27. Silber J, Jacobson A, Ozawa T, et al. miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. PLoS One. 2012;7(3):e33844.
28. Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 2012;31(15):1884-1895.
29. Godlewski J, Nowicki MO, Bronisz A, et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008;68(22):9125-9130.
30. Xia H, Cheung WK, Ng SS, et al. Loss of brain-enriched miR-124 enhances the stem-like traits and invasiveness of glioma cells. J Biol Chem. 2012;287(13):9962-9971.
31. Silber J, Lim DA, Petritsch C, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008;6:14.
32. Hu W, Chan CS, Wu R, et al. Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell. 2010;38(5):689-699.
33. Kim TM, Huang W, Park R, Park PJ, Johnson MD. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res. 2011;71(9):3387-3399.